TXNL4B / DIM2 antibody

Principal name

TXNL4B / DIM2 antibody

Alternative names for TXNL4B / DIM2 antibody

Thioredoxin-like protein 4B, Dim1-like protein, DLP

SwissProt ID

Q8BUH1 (Mouse), Q9NX01 (Human)

Gene ID

54957 (TXNL4B)

Available reactivities

Hu (Human)

Available hosts

Mouse

Available applications

ELISA (detection) (E(detection)), Western blot / Immunoblot (WB), Immunocytochemistry/Immunofluorescence (ICC/IF)

Background of TXNL4B / DIM2 antibody

Kit Component:
- KN201503G1, TXNL4B gRNA vector 1 in pCas-Guide vector
- KN201503G2, TXNL4B gRNA vector 2 in pCas-Guide vector
- KN201503D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector
CRISPR Manual:
CRISPR/CAS9 Genome Editing Manual

General readings

Sun X., et al. (2004) J Biol Chem 279 (31): 32839–47.
Zhang YZ., et al. (2001) Physiol. Genomics 1 (3): 109–18.

13 Item(s)

per page

CRISPR

Catalog No. Species Donor Vector  

TXNL4B - human gene knockout kit via CRISPR

TXNL4B - human gene knockout kit via CRISPR Human mBFP-Neo
1 kit / €1,290.00
  OriGene Technologies, Inc.

TXNL4B - human gene knockout kit via CRISPR

TXNL4B - human gene knockout kit via CRISPR Human Luciferase-Puro
1 kit / €1,290.00
  OriGene Technologies, Inc.

TXNL4B - human gene knockout kit via CRISPR

TXNL4B - human gene knockout kit via CRISPR Human RFP-BSD
1 kit / €1,290.00
  OriGene Technologies, Inc.

Proteins & Growth Factors

Catalog No. Species Pres. Purity Source  

TXNL4B / DIM2 (transcript variant 1)

  Recombinant protein of human thioredoxin-like 4B (TXNL4B), transcript variant 1  
TXNL4B / DIM2 Human > 80 %
Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps.
Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining.
HEK293 cells
20 µg / €680.00
  OriGene Technologies, Inc.

TXNL4B / DIM2 (transcript variant 3)

  Recombinant protein of human thioredoxin-like 4B (TXNL4B), transcript variant 3  
TXNL4B / DIM2 Human > 80 %
Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps.
Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining.
HEK293 cells
20 µg / €680.00
  OriGene Technologies, Inc.

TXNL4B / DIM2 (1-149, His-tag)

TXNL4B / DIM2 Human Purified > 90 % E. coli
0.25 mg / €1,000.00
  Acris Antibodies GmbH

TXNL4B / DIM2 (1-149, His-tag)

TXNL4B / DIM2 Human Purified > 90 % E. coli
50 µg / €370.00
  Acris Antibodies GmbH

Lysates

Catalog No.    

TXNL4B overexpression lysate

TXNL4B overexpression lysate  
0.1 mg / €280.00
  OriGene Technologies, Inc.

TXNL4B overexpression lysate

TXNL4B overexpression lysate  
0.1 mg / €280.00
  OriGene Technologies, Inc.

Human Lenti ORF Particles

Catalog No.    

Lenti ORF particles, TXNL4B (mGFP-tagged) - Human thioredoxin-like 4B (TXNL4B), transcript variant 1, 200 uL, >10^7 TU/mL

Lenti ORF particles, TXNL4B (mGFP-tagged) - Human thioredoxin-like 4B (TXNL4B), transcript variant 1, 200 uL, >10^7 TU/mL  
200 µl / €880.00
  OriGene Technologies, Inc.

Lenti ORF particles, TXNL4B (Myc-DDK tagged) - Human thioredoxin-like 4B (TXNL4B), transcript variant 1 , 200 uL, >10^7 TU/mL

Lenti ORF particles, TXNL4B (Myc-DDK tagged) - Human thioredoxin-like 4B (TXNL4B), transcript variant 1 , 200 uL, >10^7 TU/mL  
200 µl / €780.00
  OriGene Technologies, Inc.

Lenti ORF particles, TXNL4B (Myc-DDK tagged) - Human thioredoxin-like 4B (TXNL4B), transcript variant 2 , 200 uL, >10^7 TU/mL

Lenti ORF particles, TXNL4B (Myc-DDK tagged) - Human thioredoxin-like 4B (TXNL4B), transcript variant 2 , 200 uL, >10^7 TU/mL  
200 µl / €780.00
  OriGene Technologies, Inc.

Lenti ORF particles, TXNL4B (Myc-DDK tagged) - Human thioredoxin-like 4B (TXNL4B), transcript variant 3 , 200 uL, >10^7 TU/mL

Lenti ORF particles, TXNL4B (Myc-DDK tagged) - Human thioredoxin-like 4B (TXNL4B), transcript variant 3 , 200 uL, >10^7 TU/mL  
200 µl / €780.00
  OriGene Technologies, Inc.

13 Item(s)

per page
  • LinkedIn